Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

The Src Homology-2 Domains (SH2 Domains) of the Protein Tyrosine Kinase p56 lck Structure, Mechanism and Drug Design

Author(s): R. J. Broadbridge and R. P. Sharma

Volume 1, Issue 4, 2000

Page: [365 - 386] Pages: 22

DOI: 10.2174/1389450003349074

Price: $65

Abstract

Src homology 2 (SH2) domains are found in many intercellular signal-transduction proteins which bind phosphotyrosine containing polypeptide sequences with high affinity and specificity and are considered potential targets for drug discovery. The protein p56 lck is a member of the family of Src tyrosine kinase. The SH2 domain is thought to be responsible for the recruitment and regulation of p56 lck kinase activity. There have been enormous efforts in the development of SH2 domain inhibitors for diseases such as cancer, osteoporosis and other diseases. This review focuses on current understanding of SH2 domain structure, mechanism and drug discovery with an emphasis on p56 lck SH2 domain. A potential impact of the accumulated crystallographic effort on the development of methods for structure-based drug design is briefly addressed.

Keywords: Src homology, SH2 Domains, protein tyrosin, Kinase p56, T cell activation, stimulated signalling


Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy